ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST

NCT05366816 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Stromal Tumors

Interventions

DRUG: Sunitinib
DRUG: Regorafenib

Sponsor

University of Miami